Clearpoint Neuro Other Liab Over Time
| CLPT Stock | USD 11.96 0.29 2.49% |
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out Clearpoint Neuro Performance and Clearpoint Neuro Correlation. Clearpoint |
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Clearpoint Neuro. If investors know Clearpoint will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Clearpoint Neuro listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.68) | Revenue Per Share 1.158 | Quarterly Revenue Growth 0.41 | Return On Assets (0.28) | Return On Equity (0.68) |
The market value of Clearpoint Neuro is measured differently than its book value, which is the value of Clearpoint that is recorded on the company's balance sheet. Investors also form their own opinion of Clearpoint Neuro's value that differs from its market value or its book value, called intrinsic value, which is Clearpoint Neuro's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Clearpoint Neuro's market value can be influenced by many factors that don't directly affect Clearpoint Neuro's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Clearpoint Neuro's value and its price as these two are different measures arrived at by different means. Investors typically determine if Clearpoint Neuro is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Clearpoint Neuro's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Cross Equities Other Liab Analysis
Compare Clearpoint Neuro and related stocks such as Telesis Bio, Avita Medical, and Sight Sciences Other Liab Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| RCEL | 1.3 M | 1.3 M | 1.3 M | 1.3 M | 0.0 | 0.0 | 0.0 | 0.0 | 1.3 M | 471 K | 435 K | 1.6 M | 2.5 M | 2.9 M | 3 M |
| SGHT | 7 K | 7 K | 7 K | 7 K | 7 K | 7 K | 7 K | 7 K | 7 K | 213 K | 809 K | 1.9 M | 1.2 M | 1.4 M | 919.6 K |
| TMCI | (1000) | (1000) | (1000) | (1000) | (1000) | (1000) | (1000) | (1000) | (1000) | (1000) | (1000) | (1000) | (1000) | (900) | (945) |
| NPCE | 1.7 M | 1.7 M | 1.7 M | 1.7 M | 1.7 M | 1.7 M | 1.7 M | 1.7 M | 1.7 M | 1.7 M | 1.6 M | 911 K | 911 K | 819.9 K | 1.1 M |
| INGN | 164 K | 164 K | 164 K | 1 M | 2.9 M | 5.3 M | 9.1 M | 14.1 M | 18.9 M | 47.8 M | 47.4 M | 34.5 M | 22.5 M | 25.9 M | 20.4 M |
| SRDX | 50 K | 2.4 M | 2.1 M | 2.1 M | 2.1 M | 15.9 M | 15.2 M | 20.4 M | 17.1 M | 15.5 M | 24.7 M | 17.9 M | 17.9 M | 20.6 M | 10.9 M |
| LUNG | 127 K | 127 K | 127 K | 127 K | 127 K | 127 K | 127 K | 127 K | 127 K | 43 K | 62 K | 37 K | 94 K | 84.6 K | 58.1 K |
| APYX | 419 K | 314 K | 85 K | 5.7 M | 12.6 M | 849 K | 781 K | 388 K | 519 K | 519 K | 787 K | 1.5 M | 1.6 M | 1.8 M | 1.8 M |
| LIVN | 209 K | 5.4 M | 5.5 M | 5.2 M | 7.9 M | 294.6 M | 209.2 M | 219.9 M | 409.4 M | 209.1 M | 299 M | 163.7 M | 242.1 M | 278.5 M | 292.4 M |
| ELMD | 8.9 K | 8.9 K | 8.9 K | 8.9 K | 8.9 K | 8.9 K | 8.9 K | 8.9 K | 8.9 K | 8.9 K | 8.9 K | 8.9 K | 8.9 K | 8 K | 7.1 K |
| KIDS | 1.5 M | 1.5 M | 1.5 M | 1.5 M | 1.5 M | 63 K | 63 K | 63 K | 63 K | 63 K | 49.2 M | 48.3 M | 17.2 M | 19.8 M | 25.6 M |
| NARI | 1.4 M | 1.4 M | 1.4 M | 1.4 M | 1.4 M | 1.4 M | 1.4 M | 1.4 M | 1.4 M | 1.4 M | 1.4 M | 1.4 M | 1.4 M | 1.3 M | 1.1 M |
| OM | 143 K | 143 K | 143 K | 143 K | 143 K | 143 K | 143 K | 143 K | 143 K | 351 K | 810 K | 1 M | 264 K | 303.6 K | 572.2 K |
| INSP | 53 K | 53 K | 53 K | 53 K | 53 K | 53 K | 53 K | 157 K | 40 K | 40 K | 85 K | 134 K | 146 K | 167.9 K | 112.8 K |
| TELA | 2.6 M | 2.6 M | 2.6 M | 2.6 M | 2.6 M | 2.6 M | 2.6 M | 2.6 M | 1.6 M | 4 K | 380 K | 380 K | 380 K | 342 K | 324.9 K |
Clearpoint Neuro and related stocks such as Telesis Bio, Avita Medical, and Sight Sciences Other Liab description
My Equities
My Current Equities and Potential Positions
| Clearpoint Neuro | CLPT |
Specialization | Health Care, Health Care Equipment & Services |
| Location | California; U.S.A |
| Exchange | NASDAQ Exchange |
USD 11.96
Additional Tools for Clearpoint Stock Analysis
When running Clearpoint Neuro's price analysis, check to measure Clearpoint Neuro's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Clearpoint Neuro is operating at the current time. Most of Clearpoint Neuro's value examination focuses on studying past and present price action to predict the probability of Clearpoint Neuro's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Clearpoint Neuro's price. Additionally, you may evaluate how the addition of Clearpoint Neuro to your portfolios can decrease your overall portfolio volatility.